Tumor/Normal Counterpart Microvessel Density Ratio has a Better Correlation with Clinicopathologic Parameters in Endometrial Carcinoma than Tumor Microvessel Density Alone
Authors:
- Ming-Ping WuMWMing-Ping Wu
- Yu-Jen ChengYCYu-Jen Cheng
- Yue-Shan LinYLYue-Shan Lin
- Chieh-Yi KangCKChieh-Yi Kang
- Kuo-Feng HuangKHKuo-Feng Huang
- Ching-Cherng TzengCTChing-Cherng Tzeng
Open Access
- 1 December 2004
- journal article
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 43 (4) , 199-205
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thrombospondin-1 Acts as a Fence to Inhibit Angiogenesis That Occurs During Cervical CarcinogenesisThe Cancer Journal, 2004
- Heterogeneity of Endothelial CellsThe American Journal of Pathology, 1999
- Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of Stage I endometrial carcinomaCancer, 1999
- Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomasInternational Journal of Cancer, 1999
- Endometrial Carcinoma Associated with Hyperplasia— Immunohistochemical Study of Angiogenesis and p53 ExpressionGynecologic Oncology, 1999
- Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancersCancer Letters, 1998
- Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?American Journal of Obstetrics and Gynecology, 1996
- Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium.Journal of Clinical Investigation, 1996
- The p53 Tumor Suppressor Gene Inhibits Angiogenesis by Stimulating the Production of ThrombospondinCold Spring Harbor Symposia on Quantitative Biology, 1994
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971